These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31336198)

  • 1. Rate of Reoperation Decreased Significantly After Year 2002 in Patients With Crohn's Disease.
    Shinagawa T; Hata K; Ikeuchi H; Fukushima K; Futami K; Sugita A; Uchino M; Watanabe K; Higashi D; Kimura H; Araki T; Mizushima T; Itabashi M; Ueda T; Koganei K; Oba K; Ishihara S; Suzuki Y
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):898-907.e5. PubMed ID: 31336198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type.
    Nagata Y; Esaki M; Moriyama T; Hirano A; Umeno J; Maehata Y; Torisu T; Matsumoto T; Kitazono T
    J Gastroenterol; 2019 Apr; 54(4):330-338. PubMed ID: 30244398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
    Safroneeva E; Vavricka SR; Fournier N; Pittet V; Peyrin-Biroulet L; Straumann A; Rogler G; Schoepfer AM;
    Aliment Pharmacol Ther; 2015 Oct; 42(8):977-89. PubMed ID: 26271358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.
    Yu CS; Jung SW; Lee JL; Lim SB; Park IJ; Yoon YS; Kim CW; Yang SK; Ye BD; Park SH; Han M; Kim JC
    Inflamm Bowel Dis; 2019 Aug; 25(9):1559-1568. PubMed ID: 30753560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn's Disease.
    Huang Y; Yao D; Guo F; Zhou Z; Li Y
    J Invest Surg; 2022 Jun; 35(6):1357-1365. PubMed ID: 34983280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
    Targownik LE; Benchimol EI; Bernstein CN; Singh H; Lix L; Tennakoon A; Leung S; Aviña A; Coward S; Jones J; Kaplan G; Murthy SK; Nguyen GC; Peña-Sánchez JN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1788-1798.e2. PubMed ID: 30448599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat intestinal resections increase the risk of recurrence of Crohn's disease.
    Riss S; Schuster I; Papay P; Mittlböck M; Stift A
    Dis Colon Rectum; 2013 Jul; 56(7):881-7. PubMed ID: 23739195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
    Kotze PG; Saab MP; Saab B; da Silva Kotze LM; Olandoski M; Pinheiro LV; Martinez CA; Ayrizono ML; Magro DO; Coy CS
    Dig Dis Sci; 2017 Feb; 62(2):456-464. PubMed ID: 27933472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn's Disease?
    Bolckmans R; Kalman T; Singh S; Ratnatunga KC; Myrelid P; Travis S; George BD
    Dis Colon Rectum; 2020 Feb; 63(2):200-206. PubMed ID: 31842162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence Rates for Surgery in Crohn's Disease Have Decreased: A Population-based Time-trend Analysis.
    Dittrich AE; Sutton RT; Haynes K; Wang H; Fedorak RN; Kroeker KI
    Inflamm Bowel Dis; 2020 Nov; 26(12):1909-1916. PubMed ID: 31895949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevalence of Concomitant Skip Small Bowel Lesions in Crohn's Disease and Their Effects on Reoperation in Patients Undergoing Ileocolic Resection.
    Qian W; Gao L; Huang L; Guo Z; Cao L; Gong J; Li Y; Zhu W
    J Gastrointest Surg; 2022 Nov; 26(11):2330-2341. PubMed ID: 36006588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic features of Crohn's disease associated with failure of medical treatment.
    Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Intervention with Infliximab Prevents Reoperation in Crohn's Disease: A Single-Center Retrospective Analysis.
    Ishii M; Tarumi KI; Shiotani A; Kamada T; Fujita M; Matsumoto H; Murao T; Manabe N; Kusunoki H; Hata J; Haruma K
    Digestion; 2017; 96(3):158-165. PubMed ID: 28858864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Morbidity Risks Following Ileocolic Resection for Crohn's Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients.
    Jouvin I; Lefevre JH; Creavin B; Pitel S; Chafai N; Tiret E; Beaugerie L; Parc Y;
    Inflamm Bowel Dis; 2018 Jan; 24(2):422-432. PubMed ID: 29361093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for postoperative recurrence after primary bowel resection in patients with Crohn's disease.
    Yang KM; Yu CS; Lee JL; Kim CW; Yoon YS; Park IJ; Lim SB; Park SH; Ye BD; Yang SK; Kim JC
    World J Gastroenterol; 2017 Oct; 23(38):7016-7024. PubMed ID: 29097874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trend and risk factors for reoperation in Crohn's disease in Japan.
    Watanabe T; Sasaki I; Sugita A; Fukushima K; Futami K; Hibi T; Watanabe M
    Hepatogastroenterology; 2012 Jun; 59(116):1081-6. PubMed ID: 22580659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with postoperative recurrence and repeat surgery in Japanese patients with Crohn's disease.
    Kusaka J; Shiga H; Kuroha M; Kimura T; Kakuta Y; Endo K; Kinouchi Y; Shimosegawa T
    Int J Colorectal Dis; 2017 Oct; 32(10):1407-1413. PubMed ID: 28735411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease.
    Rinawi F; Assa A; Hartman C; Mozer Glassberg Y; Friedler VN; Rosenbach Y; Silbermintz A; Zevit N; Shamir R
    Inflamm Bowel Dis; 2016 Dec; 22(12):2917-2923. PubMed ID: 27755214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
    Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients.
    Lightner AL; McKenna NP; Alsughayer A; Loftus EV; Raffals LE; Faubion WA; Moir C
    J Pediatr Surg; 2019 Oct; 54(10):2162-2165. PubMed ID: 30773391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.